These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21494763)

  • 1. Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome.
    Saetta AA; Levidou G; El-Habr EA; Panayotidis I; Samaras V; Thymara I; Sakellariou S; Boviatsis E; Patsouris E; Korkolopoulou P
    Virchows Arch; 2011 Jun; 458(6):749-59. PubMed ID: 21494763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT.
    El-Habr EA; Tsiorva P; Theodorou M; Levidou G; Korkolopoulou P; Vretakos G; Petraki L; Michalopoulos NV; Patsouris E; Saetta AA
    Clin Neuropathol; 2010; 29(4):239-45. PubMed ID: 20569675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.
    Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Fragkou P; Boviatsis E; Themistocleous MS; Petraki K; Vrettakos G; Sakalidou M; Samaras V; Zisakis A; Saetta A; Chatziandreou I; Patsouris E; Piperi C
    Br J Cancer; 2013 May; 108(10):2142-52. PubMed ID: 23619925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
    Piperi C; Samaras V; Levidou G; Kavantzas N; Boviatsis E; Petraki K; Grivas A; Barbatis C; Varsos V; Patsouris E; Korkolopoulou P
    Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.
    Rodriguez EF; Scheithauer BW; Giannini C; Rynearson A; Cen L; Hoesley B; Gilmer-Flynn H; Sarkaria JN; Jenkins S; Long J; Rodriguez FJ
    Acta Neuropathol; 2011 Mar; 121(3):407-20. PubMed ID: 21113787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
    Korkolopoulou P; Levidou G; Saetta AA; El-Habr E; Eftichiadis C; Demenagas P; Thymara I; Xiromeritis K; Boviatsis E; Thomas-Tsagli E; Panayotidis I; Patsouris E
    Hum Pathol; 2008 Aug; 39(8):1143-52. PubMed ID: 18495209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.
    Zhang F; Liu Y; Zhang Z; Li J; Wan Y; Zhang L; Wang Y; Li X; Xu Y; Fu X; Zhang X; Zhang M; Zhang Z; Zhang J; Yan Q; Ye J; Wang Z; Chen CD; Lin W; Li Q
    Sci Rep; 2016 Feb; 6():20882. PubMed ID: 26864347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance.
    Antonelli M; Massimino M; Morra I; Garrè ML; Gardiman MP; Buttarelli FR; Arcella A; Giangaspero F
    Neuropathology; 2012 Apr; 32(2):133-8. PubMed ID: 21978279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
    Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
    Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
    Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
    Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors.
    Song M; Finley SD
    Cell Commun Signal; 2020 Jul; 18(1):114. PubMed ID: 32680529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.
    Mäkelä K; Nordfors K; Finne J; Jokilammi A; Paavonen T; Haapasalo H; Korja M; Haapasalo J
    BMC Cancer; 2014 Aug; 14():623. PubMed ID: 25164322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of the parameters related to prognosis of astrocytoma].
    Zhong D; Li X; Zhang G
    Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):345-9. PubMed ID: 11769730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A quantitative pathological study on angiogenesis, vascular endothelial growth factor and inducible nitric oxide synthase in astrocytomas].
    Bian X; Du L; Chen Z; Shi J; Liu F
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):23-6. PubMed ID: 11866952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Hum Pathol; 2006 Aug; 37(8):1022-31. PubMed ID: 16867865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.
    Matusan-Ilijas K; Behrem S; Jonjic N; Zarkovic K; Lucin K
    Pathol Oncol Res; 2008 Sep; 14(3):293-8. PubMed ID: 18493866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.